Has John Houri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,049 in general payments to John Houri, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Houri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Houri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Houri, MD

Rheumatology · Stuart, FLNPI 1609895101

Payments from drug & device makers

$1,049in general payments, 2019–2025

Across 57 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$424
Amgen$311
AbbVie$120
Pfizer$120
Genentech USA, Inc.$74

What the payments were for

Food & beverage$1,049100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	26	$424
Amgen(2 entities)	16	$311
AbbVie	5	$120
Pfizer	6	$120
Genentech USA, Inc.	4	$74

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EVENITY$119

How this compares

$1,049 in reported general payments places this provider in the 20th percentile of 453 rheumatology providers in Florida.

See all rheumatology providers in Florida →

Medicare billing

Part B allowed, 2024

$2,503,924

Medicare patients

1,001

Services billed

133,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	36	$244,702
Enbrel SureclickEtanercept	23	$170,766
Cosentyx SyringeSecukinumab	13	$93,646
Orencia ClickjectAbatacept	13	$77,432
BenlystaBelimumab	15	$64,945
Hydroxychloroquine Sulfate	296	$11,035
Ambien CrZolpidem Tartrate	13	$7,218
MethotrexateMethotrexate Sodium	177	$5,921
Celecoxib	88	$4,106
Leflunomide	49	$3,382
Prednisone	386	$3,135
Mycophenolate Mofetil	18	$2,740
Duloxetine Hcl	94	$2,737
Methylprednisolone	145	$2,697
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	75	$2,272

Paid to pharmacies, not to this prescriber.

Other rheumatology in Stuart

Martha Hernandez IllasFort Lauderdale$25M
Carlos SesinMiami Beach$19M
Guillermo ValenzuelaPlantation$14.2M
Marimer Rensoli VelazquezMiami$12.2M
Robert LevinClearwater$11M
Jigar ShahMargate$5.6M
Michael BubbGainesville$3.3M
Vipul JoshiBrandon$3.1M
Alvin WellsDestin$2.9M
Benidecto FernandezHialeah$2.9M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →